Publication Ethics and Malpractice Statement

Publisher platform: Mentisia Research and Publishing. The European Journal of Medicine and Natural Sciences (EJMN) is an independent, peer-reviewed journal. EJMN follows the principles and flowcharts of the Committee on Publication Ethics (COPE).

1. Aims, Scope and Readership

EJMN publishes original research on human health and on the natural and pharmaceutical sciences behind it, for researchers, academics and practitioners worldwide. The areas covered are:

Clinical medicine, surgery and rehabilitation – diagnosis, treatment, case reports, physiotherapy.
Dentistry and oral health
Pharmacy and pharmacology – drug utilisation, adverse reactions, pharmaco-economics, pharmaceutical formulation, medicines safety and regulation.
Natural products and biotechnology – bioactive compounds, antioxidant and antimicrobial activity, marine and plant sources, biomaterials, ethnobotany.
Public health and epidemiology – infectious disease, vaccination, antimicrobial resistance, maternal and child health, health inequalities, pandemics.
Health systems – management, leadership, economics, quality and patient safety, patient satisfaction.
Mental health and clinical psychology – clinical and psychotherapeutic research.
Health law, bioethics and patients’ rights
Environmental health and ecology
Medical and nursing education
Sport and exercise science
History of medicine and traditional medicine – treated in a scholarly, evidence-based way.

Outside the scope: manuscripts without a clear link to health, medicine or the natural sciences – for example finance, marketing and consumer behaviour, fashion, general organisational psychology, theology or philosophy as such, and legal or economic studies unrelated to health or the environment – are not considered.

The complete statement is on the About the Journal page.

2. Publisher and Editorial Responsibility

EJMN is published by Mentisia Research and Publishing, which provides the publishing platform and the technical and operational workflow.
Scientific decisions are made by the journal's editors on the basis of independent peer review, free of influence from the publisher or from commercial considerations.

3. Peer Review

All scientific submissions undergo double-blind peer review by at least two independent external experts. EJMN does not guarantee acceptance or accelerated review. Steps: submission and pre-screening (technical, ethical and similarity checks; an acknowledgement of receipt is issued, not an acceptance); external review; recommendation (accept, minor revision, major revision, reject); revision and final decision, taken impartially and without demographic, geographic or institutional bias. See the Peer Review Procedure.

4. Authorship and Manuscript Criteria

Authorship: authors made significant contributions to the conception, design, research, data analysis, drafting or critical revision; all co-authors approve the final version before submission.
Originality: only original manuscripts not published elsewhere, in whole or in part, are considered; multiple or redundant submission is not accepted.
Citation integrity: excessive self-citation, forced citation and references not justified in the text are unacceptable.
Manuscript order: title (with authors, affiliations and corresponding e-mail), abstract, main body, references; tables and figures are embedded in the text; essential data may be published as supplementary material without duplicating figures or tables.

5. Generative AI and AI-Assisted Technologies

AI tools may be used only to improve readability, language or organisation; they never replace critical thinking, analysis or data interpretation.
Authors remain accountable for all content, including AI-assisted output and citations.
AI tools cannot be authors.
Use in writing must be disclosed in a statement above the references. See the Generative AI Policy.

6. Research Misconduct and Ethical Oversight

Plagiarism: zero tolerance; manuscripts are checked for similarity before review. Fabrication, falsification and plagiarism lead to rejection or retraction.
Data and reproducibility: authors must be able to supply the data, protocols or calculations underlying their results on request, and must disclose conflicts of interest and funding.
Human and animal research: approval from the competent institutional ethics board, informed consent (and guardian consent for minors) must be stated; personal identifiers are removed.
Sex and gender: authors and editors apply sex and gender sensitivity where relevant.

7. Post-Publication Discussion, Complaints and Corrections

Published articles are not withdrawn. Significant errors are corrected by a corrigendum/erratum, a separate notice linked to the original article.
If misconduct, fabrication or fatal flaws invalidate the conclusions, the editors and publisher issue a retraction following COPE guidelines.
Complaints and appeals against editorial decisions are investigated by the journal management following COPE flowcharts. They may be sent to [email protected].

8. Copyright, Licensing and Open Access

EJMN is fully open access: articles are free to read, download, copy and distribute immediately.
Articles are licensed under CC BY-NC-SA 4.0; the licence appears in the metadata and on every article.
Authors retain copyright and grant EJMN the right of first publication; the copyright holder is named on every article.
Authors may self-archive the published version in repositories and on personal websites.

9. Financial Policies

APC: an Article Processing Charge of €220 covers technical operations, copyediting, typesetting, metadata and infrastructure.
No submission fees: there is no charge for submission or peer review. The APC is invoiced only after acceptance, and payment has no influence on editorial decisions or guarantee of publication.

10. Publishing Schedule, Access and Archiving

Periodicity: three issues a year (28 April, 28 August, 28 December). Late submissions may be deferred to the next issue.
Distribution: online as HTML and paginated PDF files.
Preservation: articles are preserved in the PKP Preservation Network and on the publisher's servers; a DOI is registered with Crossref for each article.

11. Advertising and Direct Marketing

EJMN accepts no commercial advertising. Marketing activities by the publisher are truthful, targeted and unobtrusive, and misleading impact statistics and predatory practices are prohibited.

Journal Management

European Journal of Medicine and Natural Sciences (EJMN)
ISSN 2601-6397 (Print) | ISSN 2601-6400 (Online) | Journal e-mail: [email protected]
Publisher: Mentisia Research and Publishing (UK Company No.: 13067873)
Address: Office 1, Forest House Business Centre, 8 Gainsborough Road, London, E11 1HT, UK
Publisher e-mail: [email protected] | Phone: +44 330 027 1458